Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and borderline personality disorder study
RBR-2rnbw6Not yet recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in borderline personality disorder (BPD) (5 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoints: Baseline plasma oxytocin levels, Acute experimental response to single-dose intranasal oxytocin and 1 more. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on RBR-2rnbw6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2rnbw6.